Related Experiment Videos
Intraspecies variation in the efficacy of adjunctive recombinant interferon-γ therapy against cryptococcal
Yurika Ikeda-Dantsuji1, Shigeki Nakamura1, Hideaki Ohno2
1Department of Chemotherapy and Mycoses, National Institute of Infectious Diseases, Tokyo.
Abstract:
The efficacy of recombinant interferon γ (rIFN-γ) for cryptococcal meningoencephalitis has been poorly understood. Compared to Cryptococcus gattii, rIFN-γ significantly improved the survival in experimental meningoencephalitis due to Cryptococcus neoformans. The number of phagocytic macrophages and the levels of inflammatory cytokines production for ex vivo co-incubation with C. neoformans were increased after rIFN-γ stimulation but not C. gattii. Intraspecies differences of phagocytosis by the rIFN-γ-activated macrophages might be associated to the severity of cryptococcal infection.
Insights
Recombinant interferon gamma (rIFN-γ) improved survival in experimental cryptococcal meningoencephalitis caused by Cryptococcus neoformans, unlike Cryptococcus gattii. This suggests rIFN-γ may be a potential therapeutic agent for specific fungal infections.
Area of Science:
- Immunology
- Infectious Diseases
- Mycology
Background:
- Cryptococcal meningoencephalitis is a severe fungal infection with limited treatment options.
- The role of recombinant interferon gamma (rIFN-γ) in treating cryptococcal infections remains unclear.
- Distinct species of Cryptococcus, such as C. neoformans and C. gattii, exhibit varying virulence and host responses.
Purpose of the Study:
- To investigate the efficacy of rIFN-γ in experimental cryptococcal meningoencephalitis.
- To compare the effects of rIFN-γ on infections caused by C. neoformans versus C. gattii.
- To explore the immunomodulatory mechanisms of rIFN-γ in response to Cryptococcus species.
Main Methods:
- Experimental meningoencephalitis models were established using C. neoformans and C. gattii.
- Mice were treated with rIFN-γ, and survival rates were monitored.
- Ex vivo co-incubation assays were performed to assess macrophage phagocytosis and cytokine production following rIFN-γ stimulation.
- Key inflammatory cytokine levels were quantified.
Main Results:
- rIFN-γ significantly improved survival in experimental meningoencephalitis induced by C. neoformans, but not C. gattii.
- rIFN-γ stimulation increased the number of phagocytic macrophages and inflammatory cytokine production when co-incubated with C. neoformans, but not C. gattii.
- Differences in phagocytosis by rIFN-γ-activated macrophages were observed between Cryptococcus species.
Conclusions:
- rIFN-γ demonstrates species-specific efficacy against cryptococcal meningoencephalitis, particularly for C. neoformans infections.
- The enhanced immune response, including increased macrophage activity and cytokine production, contributes to rIFN-γ's therapeutic effect.
- Intraspecies variations in phagocytosis by rIFN-γ-activated macrophages may correlate with the severity of cryptococcal infections, highlighting potential therapeutic targets.